Verrica Pharmaceuticals Inc. (VRCA)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Novel Topical Solution of Cantharidin	5.12M	Log In	Log In
Novel Topical Solution of Cantharidin Growth	-43.27%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	5.12M	Log In	Log In
United States Growth	-43.27%	Log In	Log In